Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma.

MLA

Tian, Zhichao, et al. “Retrospective Review of the Activity and Safety of Apatinib and Anlotinib in Patients with Advanced Osteosarcoma and Soft Tissue Sarcoma.” Investigational New Drugs, vol. 38, no. 5, Oct. 2020, pp. 1559–69. EBSCOhost, https://doi.org/10.1007/s10637-020-00912-7.

APA

Tian, Z., Liu, H., Zhang, F., Li, L., Du, X., Li, C., Yang, J., & Wang, J. (2020). Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma. Investigational New Drugs, 38(5), 1559–1569. https://doi.org/10.1007/s10637-020-00912-7

Chicago

Tian, Zhichao, Huimin Liu, Fan Zhang, Liangyu Li, Xinhui Du, Chao Li, Jinpo Yang, and Jiaqiang Wang. 2020. “Retrospective Review of the Activity and Safety of Apatinib and Anlotinib in Patients with Advanced Osteosarcoma and Soft Tissue Sarcoma.” Investigational New Drugs 38 (5): 1559–69. doi:10.1007/s10637-020-00912-7.